StonvexLoading…
StonvexCore line items from DIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-27 | Annual 2024 2024-09-28 | Annual 2023 2023-09-30 | Annual 2022 2022-10-01 |
|---|---|---|---|---|
Revenue | $94.42B | $91.36B | $88.90B | $82.72B |
Operating Income | $17.55B | $15.60B | $12.86B | $12.12B |
Net Income | $12.40B | $4.97B | $2.35B | $3.15B |
EPS (Diluted) | $6.85 | $2.72 | $1.29 | $1.72 |
Total Assets | $197.51B | $196.22B | $205.58B | $203.63B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.70B | $6.00B | $14.18B | $11.62B |
Free Cash Flow OCF − CapEx | $10.08B | $8.56B | $4.90B | $1.06B |
Shares Outstanding | 1.90B | 1.90B | 1.80B | 1.80B |